Health
Recce Pharmaceuticals” R327 demonstrates positive efficacy against ‘flesh-eating” bacteria – Proactive Investors Australia
RECCE® 327 (R327) has been shown to reduce deadly flesh-eating bacterial count below limit of quantification within 24 hours,…
RECCE® 327 (R327) has been shown to reduce deadly flesh-eating bacterial count below limit of quantification within 24 hours, at varying concentrations.Recce Pharmaceuticals Ltd (ASX:RCE) (FSE:R9Q), a company developing new classes of synthetic anti-infectives,…
-
General19 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General23 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News23 hours agoOne Nation leader Pauline Hanson calls out supermarket giants for ‘fleecing’ customers with ‘flimsy’ paper bags
-
Noosa News18 hours agoNorman Dean Lake refused bail for allegedly threatening to kill Prime Minister Anthony Albanese